Research Article
Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
Table 1
Participant details and clinicopathological features.
| Group | Training cohort | Validation cohort | ESCC () | Normal () | ESCC () | Normal () |
| Age, years | Mean ± SD | 58 ± 9 | 57 ± 8 | 59 ± 6 | 56 ± 7 | Range | 41–88 | 38–77 | 43–75 | 40–71 | Gender | Male | 114 | 69 | 38 | 26 | Female | 34 | 25 | 22 | 14 | Smoke | | | | | Yes | 106 | 73 | 36 | 29 | No | 42 | 38 | 24 | 11 | TNM stage | 0 | 3 | | 1 | | I (IA + IB) | 17 (7 + 10) | | 8 (3 + 5) | | II (IIA + IIB) | 48 (22+ 26) | | 20 (4 + 16) | | III (IIIA + IIIB + IIIC) | 76 (32+ 14+ 30) | | 30 (15+ 2 + 13) | | IV | 4 | | 1 | | Histological grade | | | | | High (grade 1) | 50 | | 17 | | Middle (grade 2) | 84 | | 36 | | Low (grade 3) | 14 | | 7 | | Depth of tumor invasion | Tis | 3 | | 1 | | T1 | 11 | | 10 | | T2 | 19 | | 11 | | T3 | 77 | | 20 | | T4 | 38 | | 18 | | Regional lymph nodes | N0 | 77 | | 31 | | N1 | 38 | | 19 | | N2 | 21 | | 9 | | N3 | 12 | | 1 | | Size of tumor | <5 cm | 71 | | 24 | | ≥5 cm | 77 | | 36 | | Site of tumor | Upper thorax | 15 | | 10 | | Middle thorax | 101 | | 46 | | Lower thorax | 32 | | 4 | |
|
|